Skip NavigationSkip to Content

Gab1 is required for cell cycle transition, cell proliferation, and transformation induced by an oncogenic Met receptor

  1. Author:
    Mood, K.
    Saucier, C.
    Bong, Y. S.
    Lee, H. S.
    Park, M.
    Daar, I. O.
  2. Author Address

    Natl Canc Inst, Lab Prot Dynam & Signaling, Frederick, MD 21702 USA. McGill Univ, Ctr Hlth, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada. McGill Univ, Ctr Hlth, Dept Biochem, Montreal, PQ H3A 1A1, Canada. McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A1, Canada. McGill Univ, Ctr Hlth, Dept Oncol, Montreal, PQ H3A 1A1, Canada.;Daar, IO, Natl Canc Inst, Lab Prot Dynam & Signaling, Frederick, MD 21702 USA.;daar@ncifcrf.gov
    1. Year: 2006
    2. Date: Sep
  1. Journal: Molecular Biology of the Cell
    1. 17
    2. 9
    3. Pages: 3717-3728
  2. Type of Article: Article
  3. ISSN: 1059-1524
  1. Abstract:

    We have shown previously that either Grb2- or Shc-mediated signaling from the oncogenic Met receptor Tpr-Met is sufficient to trigger cell cycle progression in Xenopus oocytes. However, direct binding of these adaptors to Tpr-Met is dispensable, implying that another Met binding partner mediates these responses. In this study, we show that overexpression of Grb2-associated binder 1 (Gab1) promotes cell cycle progression when Tpr-Met is expressed at suboptimal levels. This response requires that Gab1 possess an intact Met-binding motif, the pleckstrin homology domain, and the binding sites for phosphatidylinositol 3-kinase and tyrosine phosphatase SHP-2, but not the Grb2 and CrkIl/phospholipase C gamma binding sites. Importantly, we establish that Gab1-mediated signals are critical for cell cycle transition promoted by the oncogenic Met and fibroblast growth factor receptors, but not by progesterone, the natural inducer of cell cycle transition in Xenopus oocytes. Moreover, Gab1 is essential for Tpr-Met-mediated morphological transformation and proliferation of fibroblasts. This study provides the first evidence that Gab1 is a key binding partner of the Met receptor for induction of cell cycle progression, proliferation, and oncogenic morphological transformation. This study identifies Gab1 and its associated signaling partners as potential therapeutic targets to impair proliferation or transformation of cancer cells in human malignancies harboring a deregulated Met receptor.

    See More

External Sources

  1. WOS: 000240125000001

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel